Categories: Wire Stories

Maxim Group LLC Announces Infectious Disease Virtual Conference to Be Hosted by M-Vest

New York, May 02, 2020 (GLOBE NEWSWIRE) — Maxim Group LLC, a leading full service investment banking, securities and wealth management firm today announces infectious disease virtual conference to be hosted by M-Vest.

The topic of infectious disease (ID) – particularly amid the COVID-19 pandemic – is dominating the headlines and our daily lives, making the need for new anti-infectives even greater. Indeed, significant resources are being deployed to develop methods to contain, treat and perhaps even cure COVID-19, and to prepare for the next potential pandemic.

COVID-19 is a crisis that is adversely affecting all of us, but clearly presents investment opportunities. As a leading investment bank in the healthcare sector, Maxim Group is well-positioned to connect industry experts with the investment community. We offer our virtual conference to provide a forum for investors to better understand the challenges and opportunities in the ID space.

Please join us to hear from executives representing 16 biotech/pharma companies in various stages of development, from early-stage to commercialization. The virtual conference will not just cover COVID-19, but all three categories of anti-infectives: bacterial, fungal and viral.

Date: Tuesday, May 5, 2020
Time: 10:00am – 5pm ET
Location: M-Vest.com
Panel Topics:
Non-antibiotic Anti-Infectives
Antifungals
COVID-19 Vaccines and Monitoring
COVID-19 Therapeutics

If you are interested, please RSVP at https://m-vest.com/insights/blog/Infectious-Disease-Virtual-Conference-2020.

About Maxim Group LLC

Maxim Group LLC is a full-service investment banking, securities and wealth management firm headquartered in New York. The Firm provides a full array of financial services including investment banking; private wealth management; and global institutional equity, fixed-income and derivatives sales & trading, equity research and prime brokerage services to a diverse range of corporate clients, institutional investors and high net worth individuals. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission (SEC) and the Municipal Securities Rulemaking Board (MSRB), and is a member of the following: Financial Industry Regulatory Authority (FINRA); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and NYSE Arca, Inc. To learn more about Maxim Group, visit www.maximgrp.com.

John Sergio
212-895-3552
jsergio@maximgrp.com

Alex

Recent Posts

Capstone Copper Announces 2024 Annual General and Special Meeting Results

VANCOUVER--(BUSINESS WIRE)--Capstone Copper Corp. (“Capstone” or the “Company”) (TSX:CS) (ASX:CSC) announced the voting results from…

1 hour ago

Indonesia International Remittance Market Growth and Future Opportunities 2024-2028: Rising Transaction Values and Volumes Characterize the Landscape – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indonesia International Remittance Market Business and Investment Opportunities - Analysis by Transaction Value…

1 hour ago

KCAS Bio and Crux Biolabs Announce Global Spectral Flow Cytometry Alliance

KCAS Bio continues to expand its global reach and has selected Crux Biolabs (Melbourne, Australia)…

7 hours ago

Firstsource Acquires Quintessence

Strengthens end-to-end RCM offering to healthcare providers Expands service capabilities to US physicians’ practices, and…

8 hours ago

UPCX Becomes the Main Sponsor for Coinfest Asia 2024

SINGAPORE - Media OutReach Newswire - 3 May 2024 - UPCX (UPC), a developer of…

9 hours ago

China Biological Reagents (Molecular Biology Reagents, Proteins and Cell Reagents) Industry Research 2023-2024 & 2028 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "China Biological Reagents Market (Molecular Biology Reagents, Proteins and Cell Reagents): Insights &…

9 hours ago